ArticleBlood2019

ROR1-targeted delivery of miR-29b induces cell cycle arrest and therapeutic benefit in vivo in a CLL mouse model.

Chi-Ling Chiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.